About us

Position:HOME > About us > Company Profile

Akeso Biopharma is an innovative biotechnology company headquartered at National Health Technology Park of Zhongshan Torch Development Zone in Guangdong province. Founded in March 2012 by a group of entrepreneurial returnees and led by a member of China’s 1000 Talents Program, Akeso focuses on discovering and developing innovative biologics with international intellectual rights for the treatment of a broad spectrum of diseases. We have built a world-class R & D and commercialization platform for biologics, and a rich product pipeline targeting oncology, autoimmune and inflammatory, and cadiovascular diseases. We have a modern R&D and pilot facility of 8,000 sq m and are remodeling a newly constructed GMP manufacturing site of 6,500 sq m Akeso is recognized as one of the leaders of biologics discovery in platform scale, software and hardware, new drug pipelines and R & D teams in China.

Akeso has been a pioneer in co-developing antibody drugs with strategic partners, forming collaborative relationships with many domestic and international pharmaceutical companies. In July 2015, we successfully completed a round A private placement by Shenzhen Capital Group Co., Ltd, Zhongshan Pheaton Capital Management, L. P., Shanghai CCB Capital Co., Ltd, and Shenzhen Qianhai Xinnuo Capital Co., Ltd. In November 2015, Akeso has entered into a collaboration with MSD, known as Merck in the United States and Canada, to research, develop and commercialize an immune checkpoint blocking antibody AK107 discovered by Akeso. Under the terms of the agreement, we will receive an upfront payment from MSD and up to $200 million in development and commercialization milestone payments. We will expand our strategic cooperation with pharmaceutical companies to rapidly advance our novel antibody drugs from discovery phase to market. Over the last couple of years, Akeso has earned numerous awards such as High-tech Enterprise of Guangdong Province, Engineering Laboratory of Protein and Antibody Drug Discovery in Guangdong Province, Key Overseas Chinese Entrepreneurial Team by the State Council Overseas Chinese Affairs Office, and Outstanding Entrepreneurship of Chinese Returnees by The State Ministry of Human Resources and Social Security, etc.